RLAY
Relay Therapeutics, Inc. · Healthcare
President and CEO Sanjiv Patel sold $338K of Relay Therapeutics, Inc.
Sold$337,574
$7.82Price
43,168Shares
−3%Stake
What RLAY did after the filing
- The stock from Wed, Jan 7 close, $8.18
- +6.4%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Feb 20 close.
Traded Tue, Jan 6. Filed Wed, Jan 7, 11:15 AM ET, during the session. Returns use the Jan 7 close and the Feb 20 close. Not investment advice.